What Is TMH?
TMH most commonly stands for Transmembrane Helix in bioinformatics and structural biology. It refers to an alpha-helical segment of a protein that spans a lipid bilayer membrane entirely. These regions are typically 18 to 25 amino acids long, hydrophobic, and rich in leucine, valine, isoleucine, and alanine. That's the core definition. The practical side is where things get interesting and messy. If you're coming from a wet-lab background and just got thrown into membrane protein work, the first thing you need to understand is that TMH prediction is one of those things that sounds solved but isn't. Tools like TMHMM, Phobius, and DeepTMH2 exist, and they're good. They're also imperfect. I spent months in grad school trying to reconcile conflicting predictions across tools for a GPCR construct that refused to express. Turns out the issue wasn't the biology — it was an N-terminal signal peptide that was being misclassified as a transmembrane helix by every program I ran it through. The workaround was straightforward once I knew what to look for. I ran the sequence through Phobius (which separates signal peptides from TM helices), then manually inspected the top hit against known signal peptide databases using SignalP. Confirmed it. Trimmed the first 22 residues, reran the construct, and got clean expression. The lesson: trust the tools, but verify the edge cases yourself.
How TMH Prediction Actually Works
Most modern TMH predictors use a combination of hidden Markov models and neural networks. TMHMM (the original) relies on an HMM with two hidden states for the membrane and cytoplasmic regions, plus a learning phase trained on known structures from the PDB. DeepTMH2, released more recently, uses a deep neural network architecture trained on a larger, more diverse dataset. The improvement isn't huge in everyday use — maybe a 3 to 5 percent boost in accuracy on difficult targets — but it matters when you're working with atypical sequences like those from extremophiles or engineered constructs. The key output you'll see is a per-residue probability score. A score above 0.5 usually means the residue is predicted to be in a transmembrane region. Positions with scores above 0.9 are high-confidence helix calls. The trick is looking at the pattern across the sequence, not individual residues. A single hydrophobic stretch might score well but turn out to be a buried hydrophobic core rather than a membrane-spanning helix. Context matters.
Common Pitfalls and Where These Tools Fail
Here are the things nobody tells you until you've burned through a grant cycle: Single-pass vs. multi-pass proteins. Tools assume a certain topology. If you're working with a protein that has a single transmembrane domain (like a type I membrane receptor), prediction is reliable. If you're dealing with something like an ion channel with six or more passes, the confidence drops significantly around the loops between helices. The loops themselves can contain short hydrophobic segments that get misidentified as additional TM helices. Signal anchors and signal peptides. This is the biggest source of error. A signal anchor sequence looks almost identical to a TM helix from a computational standpoint. Phobius is the best tool for disentangling these, but even it makes mistakes on non-canonical signal sequences. I've seen entire papers retracted because the authors misannotated a secreted protein as a transmembrane protein based on a single-tool prediction.
Get the Full Details
Non-alpha-helical membrane spans. Some proteins use beta-barrels instead of alpha-helices to cross membranes, particularly in outer membranes of bacteria and mitochondria. Standard TMH predictors will miss these entirely or give you nonsense results. If you suspect a beta-barrel, use tools like TOMATO or BetaPropeller instead. Short hydrophobic stretches. A 15-residue hydrophobic patch might score as a borderline TM helix. In practice, many of these turn out to be peripheral membrane associations or artifact sequences. The rule of thumb: anything under 17 residues should be treated as a prediction, not a conclusion, unless you have structural or functional data to back it up.
Practical Workflow for TMH Analysis
Here's what I actually do when I get a new sequence. It takes about 20 minutes end to end. Run the sequence through DeepTMH2 first. It gives you the most up-to-date predictions and includes topology information. Export the results. Then run the same sequence through Phobius for the signal peptide check. Compare the outputs side by side. If both tools agree on the number and position of helices, you're in good shape. If they disagree, that's where you dig deeper. I also run a basic BLAST against the non-redundant database to see if there's any homology to characterized membrane proteins. Sometimes a match to a related family immediately resolves ambiguity. For example, if your prediction shows four TM helices but the closest homolog is a known four-pass transporter, you can reasonably infer the topology even if the prediction isn't perfect.
Finally, I look at the actual sequence alignment. Hydrophobicity plots from a window of 19 to 21 residues still have value. They're not as sophisticated as machine learning models, but they're fast, transparent, and sometimes they reveal something the black-box models miss. I keep a standard Kyte-Doolittle plot in my toolbox alongside the modern predictors.
When to Abandon Prediction Entirely
There are legitimate cases where computational TMH prediction is not enough, and pretending it is wastes everyone's time. If you're publishing structure-function data, if you're designing constructs for expression, or if you're working with a novel protein family with no characterized members, you need experimental validation. Cross-linking mass spectrometry, readthrough assays with reporter fusions, and directed mutagenesis of predicted helix boundaries are the standard approaches. None of them are trivial, but they're faster than spending six months chasing a wrong topology. For routine annotation in a genome project, prediction tools are sufficient. For anything that will be used as the basis for further experiments or published claims, treat the prediction as a starting hypothesis, not a finding. The field has gotten much better over the last decade. The jump from the original TMHMM to tools like DeepTMH2 represents real progress. But membrane biology is hard, and no algorithm has solved it. The people who get it right are the ones who understand what the tools can and can't do, and who know when to stop trusting the software and start doing the experiment.
